Overview
- The new ACIP charter, posted Thursday, rewrites the panel’s mission to highlight gaps in vaccine safety research, consider cumulative effects of shots and ingredients, and track newer platforms such as mRNA vaccines.
- It shifts selection and appointment authority to the HHS secretary and widens who can serve, moving from vaccine-specific expertise to a broader mix of fields such as toxicology, biostatistics, and consumer issues.
- The charter adds non-voting seats for groups that have questioned vaccines, including Physicians for Informed Consent, the Association of American Physicians and Surgeons, the Independent Medical Alliance, and the Medical Academy of Pediatrics and Special Needs.
- A March 16 ruling by U.S. District Judge Brian E. Murphy found Kennedy’s prior reconstitution unlawful and paused many actions, and legal and public-health experts say the new rules could help HHS re-stock the panel in ways that test the court’s order.
- HHS says the renewal is a routine step, but the changes leave vaccine policy in flux, and experts warn that uncertainty could slow access to new vaccines and sow confusion for patients and clinicians who rely on ACIP to guide coverage and care.